Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

Nehal J. Lakhani, Wells A. Messersmith, Jeeyun Lee et al.|Seoul National University Open Repository (Seoul National University)|2021

Cited by 95